J. E. Davis Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 months, 2 weeks ago
J. E. Davis has an estimated net worth of at least $29.3 million*, as of Oct. 29, 2025. They own 120,480 shares of DGX stock. They have sold 94,284 shares of DGX stock since 2021, for an estimated $6.6 million.
J. E. Davis $DGX SEC Form 4 Insider Trading
J. E. Davis has filed a total of 18 insider trades in $DGX since 2021. Their most recent trade was a sale of 9,342 shares, made on Nov 25, 2025. Their largest trade was a sale of 41,004 shares, made on Nov 25, 2025. We estimate that they now own 120,480 shares of $DGX, worth an estimated $22.7 million.
Insider Trading at $DGX
There have been a total of 115 insider trades reported at $DGX since 2021, with 0 shares purchased and 1.1 million shares sold. The most active insider traders in $DGX stock have been Michael E Prevoznik, Stephen H Rusckowski, and J. E. Davis. The most recent trade was a sale of 41,004 shares reported by J. E. Davis (CEO and President), made on Nov 25, 2025.
History of Insider Stock Trades by J. E. Davis
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
DGX
|
Sale | 9,342 | Nov 25, 2025 | Nov. 28, 2025, 5:30 p.m. |
|
DGX
|
Sale | 41,004 | Nov 25, 2025 | Nov. 28, 2025, 5:30 p.m. |
|
DGX
|
Sale | 4,747 | Nov 25, 2025 | Nov. 28, 2025, 5:30 p.m. |
|
DGX
|
Sale | 7,249 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 4,905 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 2,764 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 6,950 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 5,900 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 2,493 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 2,366 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 584 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 267 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 1,493 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 902 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 453 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 750 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 1,411 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
|
DGX
|
Sale | 704 | Apr 02, 2025 | April 4, 2025, 8:29 p.m. |
$DGX Executives and Stock Owners with Insider Trades
-
Michael E Prevoznik, SVP & General Counsel
-
Stephen H Rusckowski, Chairman, CEO and President
-
J. E. Davis, CEO and President
-
Catherine T. Doherty, EVP, Regional Businesses
-
Catherine T. Doherty, SVP, Group Exec. Clin. Fran.
-
Karthik Kuppusamy, SVP, Clinical Solutions
-
Michael J Deppe, SVP, Corp. Controller & CAO
-
Patrick Plewman, SVP for Diagnostic Services
-
Catherine T. Doherty, SVP, Regional Businesses
-
Mark E Delaney, SVP & Chief Commercial Officer
-
Michael J Deppe, VP, Corp. Controller & CAO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.